Publications

Explore the Impact of Aster Insights

Aster Insights is an oncology-focused health ‚Äčinformatics solutions company, delivering rich data that enables breakthrough scientific research.

Learn how Aster Insights is advancing the fight against cancer by driving precision oncology and drug discovery.

15+

Years of Data

125+

Publications

350,000

TCC Patients

18

ORIEN Members

Filters

Research Focus

Cancer Type

Data Utilized

ORDER BY

All Publications

    Replicative Instability Drives Cancer Progression. Morris BB, Smith JP, Zhang Q, et al.

    2022

    Factors Predicting Participation in the Prospective Genomic Sequencing Study, Total Cancer Care (TCC), in Kentucky. Riggs MJ, Huang B, Chen Q, et al.

    2022

    Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma. Coleman S, Xie M, Tarhini AA, et al.

    2022

    Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma. Peres LC, Colin-Leitzinger CM, Teng M, et al.

    2022

    Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma. Hasipek M, Grabowski D, Guan Y, et al.

    2021

    Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes. Hutchcraft ML, Lin N, Zhang S, et al.

    2021

    MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma. Morris Benjamin B., Wages Nolan A., Grant Patrick A., et al.

    2021

    Metabolic Changes Are Associated with Melphalan Resistance in Multiple Myeloma. Koomen DC, Meads MB, Magaletti DM, et al.

    2021

    Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy. Zaman S, Hajiran A, Coba GA, et al.

    2021

    Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma. Mostofa A, Distler A, Meads MB, et al.

    2021

    Learn more about how we are advancing the fight against cancer.